Scleroderma history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 22: Line 22:
*[[Flatulence]]
*[[Flatulence]]
*Altered [[Bowel movement|bowel movements]]
*Altered [[Bowel movement|bowel movements]]
*[[Fatigue]]
*[[Fatigue]]<ref name="pmid19106163">{{cite journal |vauthors=Sandusky SB, McGuire L, Smith MT, Wigley FM, Haythornthwaite JA |title=Fatigue: an overlooked determinant of physical function in scleroderma |journal=Rheumatology (Oxford) |volume=48 |issue=2 |pages=165–9 |date=February 2009 |pmid=19106163 |pmc=2638541 |doi=10.1093/rheumatology/ken455 |url=}}</ref>
*[[Weakness]]
*[[Weakness]]
*[[Weight loss]]
*[[Weight loss]]

Revision as of 23:24, 19 April 2018

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma history and symptoms

CDC on Scleroderma history and symptoms

Scleroderma history and symptoms in the news

Blogs on Scleroderma history and symptoms

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

The hallmark of scleroderma is sclerodactyly. A positive history of progressive skin tightening and hardening is suggestive of scleroderma. The most common symptoms of scleroderma include skin tightening or induration, Raynaud's phenomenon and symptoms of Gastroesophageal reflux disease (GERD). Less common symptoms of scleroderma include shiny skin appearance and restricted movement of affected areas of the skin.

History and Symptoms

The hallmark of scleroderma is sclerodactyly. A positive history of progressive skin tightening and hardening is suggestive of scleroderma. The most common symptoms of scleroderma include skin tightening or induration, Raynaud's phenomenon and symptoms of Gastroesophageal reflux disease (GERD).[1]

History

Patients with scleroderma may have a positive history of:

Common Symptoms

Common symptoms of scleroderma include:

Less Common Symptoms

Less common symptoms of scleroderma include:

  • Shiny skin appearance
  • Restricted movement of affected area of skin

References

  1. 1.0 1.1 1.2 Shreiner AB, Murray C, Denton C, Khanna D (2016). "Gastrointestinal Manifestations of Systemic Sclerosis". J Scleroderma Relat Disord. 1 (3): 247–256. doi:10.5301/jsrd.5000214. PMC 5267349. PMID 28133631.
  2. 2.0 2.1 2.2 Pogorzelska-Antkowiak A, Antkowiak R (2006). "[Diagnostic and therapeutic problems of scleroderma]". Wiad. Lek. (in Polish). 59 (5–6): 392–5. PMID 17017489.
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Hudson M, Fritzler MJ, Baron M (May 2010). "Systemic sclerosis: establishing diagnostic criteria". Medicine (Baltimore). 89 (3): 159–65. doi:10.1097/MD.0b013e3181dde28d. PMID 20453602.
  4. Sandusky SB, McGuire L, Smith MT, Wigley FM, Haythornthwaite JA (February 2009). "Fatigue: an overlooked determinant of physical function in scleroderma". Rheumatology (Oxford). 48 (2): 165–9. doi:10.1093/rheumatology/ken455. PMC 2638541. PMID 19106163.

Template:WH Template:WS